TP53 and colorectal carcinoma: Because somatic TP53 mutations are common in CRC and considered a part of its pathogenesis, this was not necessarily surprising.20 However, the VAFs of all three mutations were particularly high; NCOR1 (84%), FLCN (86%), and TP53 (87%).